Vanderbilt University Medical Center
Customers
5
2 federal agencies, 3 prime contractors
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Federal obligations
$15.4M
FY2027 · USAspending.gov
Federal contracts 2
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $19.8M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Veterans Affairs
Department of Veterans Affairs |
$15.4M | FY 2027 | 5 | $7.1M → $34.7M → $33.1M → $15.4M | 36C24927N0039 |
HEART TRANSPLANT SERVICES - MODIFICATION TO UPDATE INVOICING INSTRUCTIONS. | |||||
| Department of Health and Human Services
National Institutes of Health |
$4.4M | FY 2026 | 17 | $4.8M → $3.1M → $4.4M | 75N93024C00072 |
GENETIC AND STRUCTURAL BASIS FOR VIRUS NEUTRALIZATION | |||||
Federal subcontracts received 3
Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| Washington University, The | $1.9M | FY 2025 | 1 | 75D30123F00002 | |
SCOPE OF WORK - VUMC THE OVERALL PURPOSE OF THE PROJECT INCLUDES THE FOLLOWING 4 TASKS: DESIGN A MULTI-SITE STUDY OF INFLUENZA TRANSMISSION WITHIN HOUSEHOLDS, ENROLL ELIGIBLE HOUSEHOLDS AND CONDUCT PROSPECTIVE STUDY ACTIVITIES, CONDUCT LABORATORY STUDIES TO CHARACTERIZE SUSCEPTIBILITY AND INFECTION, AND, PROVIDE DATA MANAGEMENT FOR SITUATIONAL AWARENESS AND ANALYSES. TO ACCOMPLISH THE PROJECT€„¢S OBJECTIVES, OUR VUMC SITE WILL ENROLL AND FOLLOW APPROXIMATELY 150 HOUSEHOLDS. VUMC WILL SERVE AS A SUBCONTRACTOR TO WASHINGTON UNIVERSITY AND WILL SERVE AS THE DATA COORDINATING CENTER (DCC) AND CENTRAL VIRAL LABORATORY FOR THE NETWORK. TO ENSURE EFFECTIVE AND EFFICIENT IDENTIFICATION OF INDEX CASES, REGARDLESS OF PRESENCE OF SYMPTOMS AND RAPID ENROLMENT AND COMPLETE FOLLOW-UP OF INDEX CASES AND HOUSEHOLD CONTACTS, WE WILL IMPLEMENT A MODIFIED CASE-ASCERTAINED STUDY DESIGN. WE WILL USE ESTABLISHED HIGH-THROUGHPUT STATE-OF-THE-ART TESTING PLATFORMS TO ACCURATELY IDENTIFY INFLUENZA INFECTIONS AND APPLY A DETAILED ALGORITHM TO DETERMINE AND VERIFY VACCINATION HISTORY. IN ADDITION, WE WILL IMPLEMENT AN INTEGRATED DATA SYSTEM FOR COLLECTION AND MANAGEMENT OF ALL STUDY ELEMENTS, THAT ENSURES REAL-TIME DATA SHARING. | |||||
| Regents Of The University Of Michigan | $780.5K | FY 2025 | 3 | 75N98026F00001 | |
VANDERBILT UNIVERSITY MEDICAL CENTER INVESTIGATORS COX, BELOW, BICK, GAMAZON AND SHAH WILL WORK WITH THE UNIVERSITY OF MICHIGAN TEAM TO IMPUTE MULTI-OMIC PHENOTYPES. THEY WILL CREATE PIPELINES FOR DEPLOYING THESE PHENOTYPES AS WELL AS AUXILIARY PHENOTYPES, AND POLYGENIC RISK SCORES INTO THE TOPMED GENOME DATA, AS WELL AS RESULTS DATABASES FOR RESULTS OF ASSOCIATION STUDIES. IN ADDITION, THE INVESTIGATORS AT VANDERBILT UNIVERSITY WILL PROVIDE ESSENTIAL OVERSIGHT ON PUBLICATION AND DATA INTERPRETATION AND PARTICIPATE IN PROJECT CALLS AND MEETINGS. | |||||
| University Of Georgia Research Foundation, INC. | $750.0K | FY 2025 | 1 | 75N93021C00018 | |
CENTER FOR INFLUENZA VACCINE RESEARCH FOR HIGH RISK POPULATIONS | |||||
Alerts are coming
Get an email when Vanderbilt University Medical Center's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.